Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.55 |
| ▸ | RARB | P10826 | 3/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.46 |
| ▸ | NR0B2 | Q15466 | 2/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 5/20 | 0.46 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | RARA | P10276 | 2/20 | 0.42 |
| ▸ | RARG | P13631 | 2/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6023896 | 1.00 | HDAC11 (0.55) | HDAC11RARBPTPN11NR0B2PTGER4 | |
| SCHEMBL6022597 | 0.93 | HDAC11 (0.55) | HDAC11RARBPTPN11NR0B2PTGER4 | |
| SCHEMBL6022589 | 0.93 | HDAC11 (0.55) | HDAC11RARBPTPN11NR0B2PTGER4 | |
| SCHEMBL2391779 | 0.90 | HDAC11 (0.45) | HDAC11RARBPTPN11NR0B2HDAC2 | |
| SCHEMBL2391181 | 0.87 | HDAC11 (0.48) | HDAC11RARBPTPN11NR0B2PTGER4 | |
| SCHEMBL6022685 | 0.87 | HDAC11 (0.55) | HDAC11RARBPTGER4PTGER2PTGER1 | |
| SCHEMBL6022689 | 0.87 | HDAC11 (0.55) | HDAC11RARBPTGER4PTGER2PTGER1 | |
| SCHEMBL6022606 | 0.86 | HDAC11 (0.57) | HDAC11RARBPTPN11NR0B2PTGER4 | |
| SCHEMBL6022610 | 0.86 | HDAC11 (0.57) | HDAC11RARBPTPN11NR0B2PTGER4 | |
| SCHEMBL2395828 | 0.85 | HDAC11 (0.48) | HDAC11RARBPTPN11NR0B2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7053071-B2 | For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells | THE BURNHAM INSTITUTE (US) | 2006-05-30 | — | — | US | disclosed |
| US-20030176506-A1 | Induction of apoptosis in cancer cells | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | 2003-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176506-A1 | Induction of apoptosis in cancer cells | MCL1, BAD, BCL2 | HDAC11 347/4885RARB 577/4885PTPN11 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.